NL

Nigel Lange

Oncosil Medical Limited | Chief Executive Officer, Managing Director
Mr Lange has 31 years of experience in the medical devices industry. Since 2003, he has held various leadership roles with Sirtex Medical, a global leader in brachytherapy treatment for liver cancer. From 2003, he served as Chief Executive Officer of Sirtex's European business. Since 2017, he served as Group Chief Commercial Officer. During this time, he has also held interim roles including Interim Group CEO and Interim CEO of Asia Pacific. He is also a member of Risk Committee.

Company and Roles

Company
Title
Tenure
Since
OSL
OSL
Oncosil Medical Limited
  • Chief Executive Officer
  • Managing Director
5yrs, 5mthJan 2021

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
OSL
OSL
Oncosil Medical Limited
17/03/26106,789N/A190,187N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
OSL
OSL
Oncosil Medical Limited
17/03/26
Issued
103,039$0.550$56,671Placement
OSL
OSL
Oncosil Medical Limited
17/03/26
Expiry
14,296$0.550$7,862As advised by the company
OSL
OSL
Oncosil Medical Limited
17/03/26
Expiry
7,105$0.550$3,907As advised by the company
OSL
OSL
Oncosil Medical Limited
17/03/26
Issued
73,530$0.550$40,441Issue of options
OSL
OSL
Oncosil Medical Limited
01/12/25
Issued
114,157$1.112$126,999Director remuneration